The global critical limb ischemia treatment market is experiencing remarkable growth due to the growing prevalence of diabetes and other chronic diseases that contribute to peripheral artery disease. This condition, characterized by severely restricted blood flow to the limbs, often leads to pain, ulcers, and even amputation. The demand for effect